The primary sequence of protein determines the advanced structure of a protein, influencing a protein's function. Therefore, the sequence of a protein is essential for understanding the biological function of the protein. Gxene Biotech has developed a comprehensive protein sequencing platform to meet the diverse needs of our customers, including N-terminal and de novo sequencing. Welcome to contact us for more information.
 
De Novo Sequencing Service:

 
Protein sequence, an important physical and chemical property of proteins, which is of great significance for identification of protein species and advanced structure prediction. With the development and progress of life science technology, many protein sequencing technologies have emerged, which can be roughly divided into mass spectrometry and non-mass spectrometry. Non-mass spectrometry mainly includes Sanger method, Edman degradation method, dinitrofluorobenzene method, dansulfonyl chloride method, hydrazine hydrolysis method and carboxypeptiase method, among which Edman degradation method is the most commonly used non-mass spectrometry method.
Both mass spectrometry and Edman degradation can be used for protein sequence analysis, but there are great differences in the analysis principle and the sequence region that can be measured. Edman degradation method, a chemical method, which is a sequencing method for N-terminal amino acids. It does not need to rely on protein database to directly analyze the data and directly obtain the amino acid sequence. Through three successive chemical reactions, an N-terminal amino acid residue can be cut off, and the amino acid is identified, and then the protein with one amino acid missing is carried out the same operation again, and so on, identifying one amino acid residue each cycle. However, end-modified or blocked amino acids cannot carry out the above chemical reactions, so the Edman degradation method is powerless to N-terminally modified or blocked proteins. The quality of Edman sequencing decreases as the number of amino acids detected increases, so it is usually only used to identify the first 30-60 amino acids, and its detection length does not exceed 100 amino acids. Therefore, Edman sequencing cannot be used for full-length protein sequencing.
The protein is digested into a peptide of 5-25 amino acids by mass spectrometry, then analyzed and detected by mass spectrometer, and the collected data is matched with the theoretical sequence database to confirm the n-terminal sequence. Mass spectrometry, which can detect the closed and modified N-terminus of proteins, has become the preferred method for full-length antibody sequencing. Compared with Edman degradation method, mass spectrometry can realize the full-length sequence analysis of proteins, and can also be used for the sequence analysis of N-terminal modified proteins, breaking the limitations of Edman degradation method. In addition, mass spectrometry can also perform de novo sequencing, providing a solution for the determination of completely new or no theoretical database of protein sequences.
Gxene Biotech has high-quality Orbitrap Fusion Lumos mass spectrometer, established a perfect database combination sequencing service, can provide our customers with high quality protein sequencing services. In view of different experimental needs, our company also provides the Edman degradation method for the determination of protein N-terminal up to 67 amino acid sequence length.
 
De Novo Sequencing Service:

 
Based on the advanced mass spectrometry instrument, 'Dao Jin' PPSQ-31A, and combined with rich experience in bioinformatics analysis, Gxene Biotech has established a complete new generation of de novo sequencing platform that can achieve accurate sequencing analysis of monoclonal antibodies and proteins. After the sample is received our scientists will first identify and fragment it with six commonly used proteases: Trypsin, Chymotrypsin, Asp-N, Glu-C, Lys-C and Lys-C. Gxene Biotech is working to get the most fragmented sequences to achieve 99.99% protein coverage. The sequence information was spliced by PEAKs Studio and PEAKs Ab software and then artificially joined to perform nearly 99.99% correct protein or antibody primary sequence.
For more de novo sequencing services, please browse the antibody de novo sequencing services or contact us for further information.
 

 
Orbitrap Fusion Lumos Mass spectrometer is a three-in-one combined mass spectrometer, which is equipped with a new atmospheric pressure ion source, advanced quadrupole technology, ultra-high field Orbitrap analyzer and the latest two-pressure linear ion trap, which is the most advanced mass spectrometer. Orbitrap Fusion Lumos is designed to expand proteomics, biopharmaceutical, and metabolomics applications through advanced performance, including applied isotope labeling quantification, low-level P-analysis, data-independent acquisition (DIA), and top-down proteomics studies. Due to its excellent performance and advanced configuration, it can be applied to many aspects, such as high-throughput protein identification, large-scale proteomic non-label quantitative analysis, protein post-translational modification PTMs analysis (such as acetylation, ubiquitination, phosphorylation, glycosylation, etc.) and protein top-down analysis.


 


N-Terminal Sequencing Service (Edman Degradation):
 
Gxene Biotech can sequence up to 60 amino acid residues from the N-terminal. The Edman method for sequencing a single amino acid cycle consists of 3 steps.
Step 1: PITC binds to free amino acids at the N-terminal of the protein under alkaline conditions.
Step 2: N-terminal residues are removed in acidic solutions.
Step 3: PITC-bound residues are converted to more stable PTH residues. After on-line analysis by HPLC, amino acids were determined according to elution time.

 

Sequencing Procedure:
 
 

Sample Requirement:
 

Services Available	Sample Type	Sample State	Standard Sample Size	Purity Requirement	Attention
Protein / antibody De novo protein sequencing	monoclonal antibody;  Antibody-drug conjugate;  recombinant protein;  Polypeptide drug	Liquid / dry powder / protein adhesive strip	≥100ug	≥90%	1. Try not to contain BSA in the sample. If there is BSA, make a column in the buffer to note the detailed concentration. 2. SDS-PAGE results of recombinant protein samples should be provided to provide information on whether they are dimerized or polymerized. 3. N-terminal sequencing, C-terminal sequencing and peptide map analysis need to provide reference sequences. 4. The sample size of each hole should be at least 15 micrograms, each sample should be sent to at least 6 glue holes, stored at 4℃, placed in EP tube, soaked in deionized water, and sent in ice pack or dry ice. 5. The protein solution buffer can be pure water or PBS buffer. If there are other solution components, please indicate them in the sample information. The prepared samples were stored at -20℃, placed in EP tubes, and sent in ice packs or dry ice. 6. The protein powder is freeze-dried from pure water or PBS buffer, and contains other solution ingredients, please indicate in the sample information. The prepared samples were put into EP tubes and sent at room temperature or in ice packs; 8. Prior communication is required before sending samples.
Peptide coverage analysis			≥100ug	≥90%
N-terminal amino acid sequence analysis			≥100ug	≥90%

 

Service Characteristics:
 
-- Identify recombinant protein expression and pulldown products.
-- Validation of expressed products in cell lines.
-- Validation of N-terminal sequences of antibody biosimilar.
 

Service Highlights:
 
--Unparalleled protein sequencing accuracy.
--99.99% protein sequence coverage and confidence.
--Strict quality control system and strong analytical capabilities.